> Search > Breast
Listing analysis and research matching Breast:
On March 13 2007 GlaxoSmithKline's cancer drug Tykerb (lapatinib ditosylate) was approved by the FDA for the treatment of patients with advanced or metastatic breast cancer. Targeted to patients who carry the HER2 gene, the approval opens up partnership opportunities in the field of diagnosis and pharmacogenomics.
Silico Research is an independent research company that conducts research and provides data and advice on issues that impact innovation and research driven industries including the life sciences, health care, technology and energy. The areas covered by our research expertise include alliances, partnerships, technology, patents and intellectual property.
Click here to find out more.
Alliances Biotechnology Cancer China Collaboration Partnering Patents Pfizer Pharmaceuticals Research
1 Home page
2 BMS partnerships
3 Recent analysis
4 Biogenerics Asia
5 Balanced scorecards
| USA | 77% |
| European Union | 7% |
| Canada | 3% |
| Germany | 3% |
| Israel | 2% |
| Netherlands | 2% |
| Australia | 1% |
| Bulgaria | 1% |
| Czech Republic | 1% |
| Estonia | 1% |
* Page views by country